World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
51
Citations
12848
World Ranking
4286
National Ranking
1652

Mary F. Kearney publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Mary F. Kearney sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 135 publications — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Mary F. Kearney D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Mary F. Kearney sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 51 D-Index — 23rd percentile

23% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Mary F. Kearney is affiliated with the National Institutes of Health in the United States. Their research primarily focuses on the fields of Medicine and Immunology and Microbiology, with a strong specialization in infectious diseases and virology. Their work spans molecular biology, epidemiology, and immunology, reflecting a multidisciplinary approach to studying complex viral infections.

The scientist's main research topics include:

  • HIV Research and Treatment
  • HIV/AIDS drug development and treatment
  • HIV/AIDS Research and Interventions
  • SARS-CoV-2 and COVID-19 Research
  • Cytomegalovirus and herpesvirus research
  • Immune Cell Function and Interaction
  • CRISPR and Genetic Engineering

Mary F. Kearney has contributed to multiple publications, often in collaboration with frequent co-authors. Notable co-authors include John W. Mellors, John M. Coffin, Michael J. Bale, Jason W. Rausch, and Adam A. Capoferri.

Frequent venues for publication include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Viruses
  • Proceedings of the National Academy of Sciences
  • mBio
  • UNC Libraries

Significant recent papers authored or co-authored by Mary F. Kearney include:

  • HIV-1 viremia not suppressible by antiretroviral therapy can originate from large T cell clones producing infectious virus, 2020, Journal of Clinical Investigation
  • Severe Acute Respiratory Syndrome Coronavirus 2 Viremia Is Associated With Coronavirus Disease 2019 Severity and Predicts Clinical Outcomes, 2021, Clinical Infectious Diseases
  • Low genetic diversity may be an Achilles heel of SARS-CoV-2, 2020, Proceedings of the National Academy of Sciences
  • Integration in oncogenes plays only a minor role in determining the in vivo distribution of HIV integration sites before or during suppressive antiretroviral therapy, 2021, PLoS Pathogens
  • Dynamic Shifts in the HIV Proviral Landscape During Long Term Combination Antiretroviral Therapy: Implications for Persistence and Control of HIV Infections, 2020, Viruses

Best Publications

  • Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy

    N. M. Archin;A. L. Liberty;A. D. Kashuba;S. K. Choudhary

  • Specific HIV integration sites are linked to clonal expansion and persistence of infected cells

    F. Maldarelli;X. Wu;L. Su;F. R. Simonetti

  • Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome.

    Qin Yu;Renate König;Satish Pillai;Kristopher Chiles

  • Multiple, Linked Human Immunodeficiency Virus Type 1 Drug Resistance Mutations in Treatment-Experienced Patients Are Missed by Standard Genotype Analysis

    Sarah Palmer;Mary Kearney;Frank Maldarelli;Elias K. Halvas

  • Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy

    J. B. Dinoso;S. Y. Kim;A. M. Wiegand;S. E. Palmer;S. E. Palmer

  • B-108 Specific HIV integration sites are linked to clonal expansion and persistence of infected cells

    Frank Maldarelli;Xiaolin Wu;Ling Su;Francesco Simonetti

  • Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo

    Francesco R. Simonetti;Michele D. Sobolewski;Elizabeth Fyne;Wei Shao

  • Histone deacetylase inhibitor romidepsin induces HIV expression in CD4 T cells from patients on suppressive antiretroviral therapy at concentrations achieved by clinical dosing.

    Datsen George Wei;Vicki Chiang;Elizabeth Fyne;Mini Balakrishnan

  • The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial

    Rajesh T. Gandhi;Lu Zheng;Ronald J. Bosch;Ellen S. Chan

  • Proviruses with identical sequences comprise a large fraction of the replication-competent HIV reservoir.

    John K. Bui;John K. Bui;Michele D. Sobolewski;Brandon F. Keele;Jonathan Spindler

  • HIV-1 Expression Within Resting CD4+ T Cells After Multiple Doses of Vorinostat

    Nancy M. Archin;Rosalie Bateson;Manoj K. Tripathy;Amanda M. Crooks

  • Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection.

    Nancie M. Archin;Naveen K. Vaidya;Naveen K. Vaidya;Jo Ann D. Kuruc;Abigail L. Liberty

  • Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy

    D. McMahon;J. Jones;A. Wiegand;S. J. Gange

  • Lack of Detectable HIV-1 Molecular Evolution during Suppressive Antiretroviral Therapy

    Mary F. Kearney;Jonathan Spindler;Wei Shao;Sloane Yu

  • HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study

    Timothy J. Henrich;Hiroyu Hatano;Oliver Bacon;Louise E. Hogan

  • Human Immunodeficiency Virus Type 1 Population Genetics and Adaptation in Newly Infected Individuals

    M. Kearney;M. Kearney;F. Maldarelli;W. Shao;J. B. Margolick

  • Majority of CD4+ T cells from peripheral blood of HIV-1–infected individuals contain only one HIV DNA molecule

    Lina Josefsson;Martin S. King;Barbro Makitalo;Johan Brännström

  • Single-cell analysis of HIV-1 transcriptional activity reveals expression of proviruses in expanded clones during ART.

    Ann Wiegand;Jonathan Spindler;Feiyu F. Hong;Wei Shao

  • HIV populations are large and accumulate high genetic diversity in a nonlinear fashion

    Frank Maldarelli;Mary Kearney;Sarah Palmer;Robert Stephens

  • Blinded, Multicenter Comparison of Methods To Detect a Drug-Resistant Mutant of Human Immunodeficiency Virus Type 1 at Low Frequency

    Elias K. Halvas;Grace M. Aldrovandi;Peter Balfe;Ingrid A. Beck

Frequent Co-Authors

John M. Coffin
John M. Coffin Tufts University
John W. Mellors
John W. Mellors University of Pittsburgh
Frank Maldarelli
Frank Maldarelli National Institutes of Health
Sarah Palmer
Sarah Palmer University of Sydney
Stephen Hughes
Stephen Hughes National Cancer Institute
Brandon F. Keele
Brandon F. Keele National Institutes of Health
Rebecca Hoh
Rebecca Hoh University of California, San Francisco
David M. Margolis
David M. Margolis University of North Carolina at Chapel Hill
Joseph J. Eron
Joseph J. Eron University of North Carolina at Chapel Hill
Vineet N. KewalRamani
Vineet N. KewalRamani National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Students considering a career in microbiology can also explore related fields through flexible online programs. Those interested in healthcare data and management may benefit from pursuing an accredited online health information management degree cahiim, which prepares graduates to manage sensitive health information efficiently and maintain compliance with regulations.

For quicker entry into healthcare administrative roles, several institutions offer fast online medical billing and coding certification programs. These programs provide essential training on medical billing processes, a vital component of healthcare operations closely linked to patient care and data accuracy.

Additionally, aspiring professionals can explore a variety of medical programs online that offer convenient access to medical education beyond microbiology. These options allow students to tailor their education based on career goals and timelines.

For those aiming to impact public health policy and community health, enrolling in accredited online mph programs easy to get into can be an excellent pathway. Such programs are often designed to be more accessible, enabling students to advance in public health without extensive barriers to entry.

Best Scientists Citing Mary F. Kearney

Trending Scientists

Recently Published Articles